TrialLancet (London, England)2010
Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.
Richard E Pratley et al.PubMed ↗Publisher ↗
The primary results report of NCT00700817. Its numbers are set against the trial’s posted results below.
No numbers read from the abstract.
Against the trial’s posted results
- Same as the trial’s posted resultThis paper difference −0.60 (−0.77 to −0.43)Posted, primary outcome difference −0.60 (−0.77 to −0.43), p = 0.0001Mean Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) at Week 26
210 papers cite itlatest 60 shown
this paperpooled ittrialcites it